Consistent with this, the combination treatment significantly decreased VEGF and sVEGFR-2 levels in the serum and pleural exudates of LLC xenograft-bearing mice, which likely translates to decreased neo-angiogenesis, normalised tumour blood vessels, and a more balanced tumour microenvironment. Here, VEGFA is linked to neoplasm.